Results 71 to 80 of about 2,813 (193)
Recognition of and treatment recommendations for oligometastatic disease in multidisciplinary tumor boards [PDF]
BACKGROUND AND INTRODUCTION Growing evidence supports a combined modality treatment strategy for patients with oligometastatic disease. However, lack of phase III trial data and uncertainties around patient selection highlight the importance of ...
Andratschke, Nicolaus; https://orcid.org/ +13 more
core +1 more source
Current status of pancreatic cancer with oligometastasis
Pancreatic cancer is the seventh leading cause of death worldwide, with ductal adenocarcinoma as the most frequent neoplasm. Half of the patients who are diagnosed have metastases at the time of diagnosis.A review of the treatment of resectable pancreatic adenocarcinoma with oligometastatic disease was carried out in order to present an overview of the
Óscar, Chapa-Azuela +6 more
openaire +2 more sources
ABSTRACT Background Surgical resection is the standard treatment for pulmonary metastases from colorectal cancer, but its safety and long‐term efficacy in medically inoperable patients remain limited. Percutaneous cryoablation is a minimally invasive alternative to surgical resection and has gained increasing attention in recent years.
Shun Yorimori +16 more
wiley +1 more source
We retrospectively analyzed 31 patients with NSCLC treated with platinum retreatment who relapsed after perioperative platinum therapy and surgery. PFS was significantly longer in the ICI‐chemo group than in the chemo group. Adding ICI to platinum retreatment may be an effective option for this population.
Toshiaki Takakura +6 more
wiley +1 more source
The role of metastasis-directed therapy and local therapy of the primary tumor in the management of oligometastatic prostate cancer [PDF]
Oligometastasis has been proposed as an intermediate stage of cancer spread between localized disease and widespread metas-tasis. Oligometastatic malignancy is now being diagnosed more frequently as the result of improvements in diagnostic modalities ...
Jongchan Kim, Won Sik Ham, Jee Soo Park
core +2 more sources
We systematically reviewed conversion therapy for esophageal squamous cell carcinoma and propose a response‐based treatment strategy for cT4b and M1 disease. For cT4b, we emphasize definitive chemoradiotherapy with timed re‐evaluation and selective salvage or chemoselection to surgery; for M1, conversion is reserved for limited‐burden responders with ...
Eisuke Booka, Hiroya Takeuchi
wiley +1 more source
© 2022 S. Karger AG, Basel. Copyright: All rights reserved.Introduction: The aim of this study was to investigate the clinical outcomes of metastasis-directed therapy (MDT) using stereotactic body radiotherapy (SBRT) in patients with synchronous or ...
Guler Yavas +15 more
core +1 more source
Practical management of oligometastatic gastric cancer
Gastric cancer is one of the types of cancer with a high prevalence of morbidity. The frequency of esophagogastric junction cancer, 5-year survival rates, perioperative adjuvant therapy, and standard chemotherapeutic regimens for gastric cancer vary ...
Y. Narita, K. Muro, D. Takahari
doaj +1 more source
ABSTRACT The therapeutic landscape of hepatocellular carcinoma (HCC) has been transformed by recent advancements in systemic therapies, particularly with the introduction of immune checkpoint inhibitors, expanding treatment options beyond conventional locoregional approaches.
Keiichi Akahoshi +4 more
wiley +1 more source
Testicular oligometastasis secondary to prostate cancer is rare. We present a case where a patient with locally advanced prostate cancer was treated with high-dose external beam radiotherapy and two years of androgen-deprivation therapy, followed by ...
Christopher M. Davidson +4 more
core +1 more source

